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772 Emergency surgery after percutaneous transmitral commissurotomy:
Operative versus echocardiographic findings, mechanisms of complications,
and outcomes
Praveen Kerala Varma, Mch, Sanjay Theodore, MS, Praveen Kumar Neema, MD,
Padmakumar Ramachandran, DM, Harikrishnan Sivadasanpillai, DM,
Krishna Kumar Nair, DM, and Kurur Sankaran Neelakandhan, Mch, Kerala, India
In a retrospective study, emergency surgery after percutaneous mitral commissurotomy was rare
and generally for acute, severe MR and cardiac tamponade. TTE underestimated the severity of
mitral valve pathology. MR was due to leaflet tearing.
777 Eight-year results after aortic valve replacement with the CryoLife-O’Brien
Stentless Aortic Porcine Bioprosthesis
Ivo Martinovic, MD, Ibrahim Farah, MD, Manfred Everlien, MD, Stephan Lindemann, MD,
Igor Knez, MD, Thomas Wittlinger, MD, Hans Greve, MD, PhD, and Paul Vogt, MD, PhD,
Krefeld and Giessen, Germany
A total of 206 patients with a mean age of 72.8 years were followed up prospectively as late as
8 years after aortic valve replacement with the CryoLife-O’Brien Stentless Aortic Porcine
Bioprosthesis. Clinical outcomes and hemodynamic performance were analyzed. This
bioprosthesis proved a reliable tissue valve in the aortic position.
783 Mitral valve stiffening in end-stage heart failure: Evidence of an organic
contribution to functional mitral regurgitation
K. Jane Grande-Allen, PhD, J. Edward Barber, BS, Katrina M. Klatka, BS,
Penny L. Houghtaling, MS, Ivan Vesely, PhD, Christine S. Moravec, PhD, and
Patrick M. McCarthy, MD, Houston, Tex, Cleveland, Ohio, and Chicago, Ill
Mitral valves from transplant recipient hearts were mechanically tested and found to be
significantly stiffer and less viscous than those of autopsy control hearts. This fibrotic behavior
suggests that mitral valves in failing hearts might be unable to stretch sufficiently to close,
which implies that MR might not be purely functional.
791 Prediction of the excessive perioperative bleeding in patients undergoing
coronary artery bypass grafting: Role of aspirin and platelet glycoprotein
IIIa polymorphism
W. Morawski, MD, PhD, M. Sanak, MD, PhD, M. Cisowski, MD, PhD, M. Szczeklik, MD,
W. Szczeklik, MD, PhD, J. Dropinski, MD, PhD, T. Waclawczyk, MD, R. Ulczok, MD, and
A. Bochenek, MD, PhD, Katowice and Krakow, Poland
Aspirin may cause bleeding after CABG in patients depending on platelet glycoprotein IIIa
polymorphism. In a double-blind, placebo-controlled study, aspirin substantially increased
bleeding and did not provide additional benefit. It was most unfavorable for PlA2 carriers.
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